The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1159/000526598
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2022
- Urheber
-
Borkowetz, Angelika
Linxweiler, Johannes
Fussek, Sebastian
Wullich, Bernd
Saar, Matthias
- DOI
-
10.18154/RWTH-CONV-250164
- URN
-
urn:nbn:de:101:1-2023020301341720445706
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Borkowetz, Angelika
- Linxweiler, Johannes
- Fussek, Sebastian
- Wullich, Bernd
- Saar, Matthias
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2022
Ähnliche Objekte (12)
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT
The Role of PSMA PET Imaging in Prostate Cancer Theranostics : A Nationwide Survey
Inhibitors of the prostate-specific membrane antigen (PSMA) for PET imaging and endoradiotherapy of prostate cancer
Editorial: Exploring the potential of PSMA-PET imaging on personalized prostate cancer treatment
PSMA PET/CT : joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0
The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging
⁶⁸Ga-PSMA PET for the assessment of metastatic prostate cancer
A simple approach to 18F-labeled PSMA-selective ligands for PET imaging of prostate cancer recurrence
[68Ga]Ga-PSMA-11: The First FDA-Approved 68Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
Effect of point-spread function reconstruction for indeterminate PSMA-RADS-3A lesions on PSMA-targeted PET imaging of men with prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]